An Improvement Project Around Staffs' Influenza Vaccine Uptake

Status Completed

Clinical Trial Summary

To reach seasonal vaccination against influenza targets, University Hospitals Birmingham (UHB) already invites staff to take up the vaccination, and every November reminds staff that have not yet vaccinated to do so. The current protocol describes a randomized controlled trial (RCT) in which staff will be sent different reminders, and the investigators will compare the proportion of staff that go on to vaccinate after receiving each reminder.

Clinical Trial Description

Seasonal vaccination against influenza is recommended for NHS staff. , To increase vaccination rates, NHS England put forth a Commissioning for Quality and Innovation goal for the 2018/2019 season of 75%. University Hospitals Birmingham NHS Foundation Trust (UHB) wants its vaccination rate to surpass this target. Since staff get infected outside of the hospital and from patients staff vaccination does not provide significant 'herd immunity'

To reach past targets, every September UHB already invites staff to take up the vaccination, and regularly reminds staff that have not yet vaccinated to do so. The current protocol describes a randomized controlled trial (RCT) in which staff will be sent a different letter when first invited to receive vaccination, and we will compare the proportion of staff that go on to vaccinate after receiving each type of letter..

To conduct the RCT the research team will design four letter styles. One factor will emphasize an authority figure inviting staff to vaccinate (the Chief Executive, who is also a doctor). The other factor will emphasize a competitive social norm describing vaccination rates in peer hospitals, including Addenbrooke's, Cambridge University Hospitals (which has exemplary rates) see appendix A and across American hospitals (which also have high rates). Letters will be sent to staff in the first week in October by UHB's communications team and they will be disseminated in a randomized fashion.

The UoW's role in this study is to advise the study's design and write-up the project for publication. UHB will approve the reminders, send the reminders, retrieve the data, and analyse the data. No individual-level data will be transferred across organizations. All individual-level data will be managed by authorized UHB employees, e.g., a UHB statistician will randomize staff to receive different reminders and analyze the data, and UHB's communication team to disseminate the reminders. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03637036
Study type	Interventional
Source	University of Warwick
Contact
Status	Completed
Phase	N/A
Start date	September 24, 2018
Completion date	January 4, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05509270` - Efficacy of Communication Modalities for Promoting Flu Shots	N/A
Recruiting	`NCT05479370` - Immunogenicity Trial of 3 Influenza Vaccines	Phase 3
Completed	`NCT01942824` - Adult Influenza Vaccination Text Message Reminders	N/A
Completed	`NCT01009645` - The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination	N/A
Completed	`NCT05783713` - Evaluation of the Effectiveness of a Flu Vaccination Campaign for Healthcare Workers of a Teaching Hospital: a Pre-post Study
Recruiting	`NCT03346772` - Study of Immune Responses to Influenza Vaccination	Phase 4
Completed	`NCT03104790` - Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls	Phase 4
Completed	`NCT04188483` - Effect of Selenium Supplementation on Influenza Vaccination	N/A
Completed	`NCT05836818` - PROmotion of FLU Vaccine Uptake in the Emergency Department - PROFLUVAXED	N/A
Completed	`NCT05785078` - Evaluation of a Flu Vaccination Program Directed at Pregnant Women Assisted at a Research Hospital in Italy.
Completed	`NCT04568785` - Effectiveness of a Brief Intervention for Acceptance of Influenza Vaccine in the Primary Care Setting	N/A
Completed	`NCT03167593` - Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.	Phase 2
Completed	`NCT01233804` - Opting In vs Opting Out	N/A
Completed	`NCT04494581` - GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region
Recruiting	`NCT04367883` - Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
Completed	`NCT06300242` - Incentives for Influenza Vaccination	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.